Saturday, July 25, 2026
Courthouse News Service
Saturday, July 25, 2026 | Back issues
Courthouse News Service Courthouse News Service

$4.8 Billion Merger

Directors are selling Spark Therapeutics too cheaply through an unfair process to Roche Holdings, for $114.50 per share or $4.8 billion, shareholders claim in a federal class action.

WILMINGTON, Del. — Directors are selling Spark Therapeutics too cheaply through an unfair process to Roche Holdings, for $114.50 per share or $4.8 billion, shareholders claim in a federal class action.

Categories / Securities

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

Loading...